BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $849,414 | -27.3% | 22,507 | -12.2% | 0.01% | -35.7% |
| Q2 2023 | $1,168,113 | +11.4% | 25,639 | -0.9% | 0.01% | +16.7% |
| Q1 2023 | $1,048,841 | -20.3% | 25,859 | +0.2% | 0.01% | -29.4% |
| Q4 2022 | $1,315,179 | -63.8% | 25,803 | -61.8% | 0.02% | -70.7% |
| Q3 2022 | $3,636,000 | -16.7% | 67,515 | -0.6% | 0.06% | -26.6% |
| Q2 2022 | $4,363,000 | -18.5% | 67,921 | -1.6% | 0.08% | +2.6% |
| Q1 2022 | $5,354,000 | +5.2% | 69,051 | +16.5% | 0.08% | +10.0% |
| Q4 2021 | $5,088,000 | +3.4% | 59,272 | -3.1% | 0.07% | +1.4% |
| Q3 2021 | $4,921,000 | -68.2% | 61,183 | -68.2% | 0.07% | -51.7% |
| Q2 2021 | $15,484,000 | -55.1% | 192,350 | -52.9% | 0.14% | -40.2% |
| Q1 2021 | $34,459,000 | -35.2% | 408,575 | -38.4% | 0.24% | -15.5% |
| Q4 2020 | $53,215,000 | -15.0% | 663,200 | -14.8% | 0.28% | -9.3% |
| Q3 2020 | $62,583,000 | -5.6% | 778,200 | +1.1% | 0.31% | -2.2% |
| Q2 2020 | $66,288,000 | +4.9% | 769,900 | -1.0% | 0.32% | -5.3% |
| Q1 2020 | $63,166,000 | -43.7% | 778,000 | -42.0% | 0.34% | -28.8% |
| Q4 2019 | $112,193,000 | +45.1% | 1,341,700 | +51.7% | 0.47% | +108.4% |
| Q3 2019 | $77,336,000 | +7.5% | 884,159 | +0.6% | 0.23% | +3.2% |
| Q2 2019 | $71,971,000 | +24051.3% | 878,760 | +23909.8% | 0.22% | +21900.0% |
| Q1 2019 | $298,000 | +23.7% | 3,660 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $241,000 | -14.5% | 3,660 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $282,000 | +4.4% | 3,660 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $270,000 | -68.0% | 3,660 | -71.8% | 0.00% | -66.7% |
| Q1 2018 | $843,000 | +0.6% | 12,960 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $838,000 | +2.9% | 12,960 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $814,000 | +5.0% | 12,960 | +1.2% | 0.00% | 0.0% |
| Q2 2017 | $775,000 | +43.8% | 12,801 | +23.1% | 0.00% | +50.0% |
| Q1 2017 | $539,000 | -79.5% | 10,400 | -87.0% | 0.00% | -81.8% |
| Q3 2015 | $2,629,000 | -85.5% | 80,033 | -83.0% | 0.01% | -84.1% |
| Q2 2015 | $18,189,000 | -47.8% | 471,185 | -7.3% | 0.07% | -55.2% |
| Q1 2015 | $34,828,000 | -20.9% | 508,433 | -15.3% | 0.15% | -17.2% |
| Q4 2014 | $44,004,000 | -2.4% | 600,413 | -4.4% | 0.19% | 0.0% |
| Q3 2014 | $45,068,000 | +296.8% | 627,944 | +299.7% | 0.19% | +295.7% |
| Q2 2014 | $11,358,000 | +102.2% | 157,096 | +105.8% | 0.05% | +88.0% |
| Q1 2014 | $5,616,000 | -73.5% | 76,323 | -74.9% | 0.02% | -72.5% |
| Q4 2013 | $21,189,000 | +49.2% | 304,659 | +41.0% | 0.09% | +145.9% |
| Q3 2013 | $14,197,000 | – | 216,125 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |